再鼎医药（09688）今日盘中大涨7.46%，引发市场关注。分析人士认为，这一涨幅可能与南向资金持续加仓有关。
据悉，4月17日，南向资金增持再鼎医药321.90万股。截至当日收盘，港股通共持有再鼎医药1.99亿股，占流通股18.10%。值得注意的是，再鼎医药近5个交易日上涨4.59%，期间港股通累计增持2105.94万股；虽然近20个交易日下跌23.62%，但港股通仍累计增持4455.90万股，显示出南向资金对该股的持续看好。
市场分析人士指出，南向资金的持续加仓可能反映了投资者对再鼎医药长期发展前景的信心。这种持续性的资金流入可能成为支撑股价的重要因素。然而，投资者仍需警惕市场风险，密切关注公司基本面变化和行业动态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.